Home/VS3 Medical/Mary Lou Mooney

ML

Mary Lou Mooney

VP, Regulatory, Clinical & Quality Affairs

Therapeutic Areas

Neurovascular Otology/Neurology

VS3 Medical Pipeline

Drug	Indication	Phase
VS3 Medical Stent System	Symptomatic Venous Sinus Stenosis (VSS)	First-in-Human

Leadership Team at VS3 Medical

Thomas C. Wilder

Chief Executive Officer

Matthew Amans, MD

Co-Founder, Chief Operating Officer

Vice President, Research & Development

View full VS3 Medical profile